These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29806744)

  • 21. Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC.
    Hong MJ; Choi YY; Jang JA; Jung HJ; Lee SY; Lee WK; Yoo SS; Lee J; Cha SI; Kim CH; Lee E; Jeon HS; Son JW; Park JY
    J Thorac Oncol; 2013 Jun; 8(6):703-10. PubMed ID: 23470291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional FLT1 Genetic Variation is a Prognostic Factor for Recurrence in Stage I-III Non-Small-Cell Lung Cancer.
    Glubb DM; Paré-Brunet L; Jantus-Lewintre E; Jiang C; Crona D; Etheridge AS; Mirza O; Zhang W; Seiser EL; Rzyman W; Jassem J; Auman T; Hirsch FR; Owzar K; Camps C; Dziadziuszko R; Innocenti F
    J Thorac Oncol; 2015 Jul; 10(7):1067-75. PubMed ID: 26134224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological features and EGFR gene mutation status in elderly patients with resected non-small-cell lung cancer.
    Nishii T; Yokose T; Miyagi Y; Daigo Y; Ito H; Isaka T; Imai K; Murakami S; Kondo T; Saito H; Oshita F; Yamada K; Matsukuma S; Tsuboi M; Nakayama H; Masuda M
    BMC Cancer; 2014 Aug; 14():610. PubMed ID: 25152277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of Patients With Resected Early-Stage Non-small Cell Lung Cancer and EGFR Mutations: Results From the IFCT Biomarkers France Study.
    Mordant P; Brosseau S; Milleron B; Santelmo N; Fraboulet-Moreau S; Besse B; Langlais A; Gossot D; Thomas PA; Pujol JL; Ricordel C; Madelaine J; Lamy R; Audigier-Valette C; Missy P; Blons H; Barlesi F; Westeel V;
    Clin Lung Cancer; 2023 Jan; 24(1):1-10. PubMed ID: 36180314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variations in multiple drug action pathways and survival in advanced stage non-small cell lung cancer treated with chemotherapy.
    Li Y; Sun Z; Cunningham JM; Aubry MC; Wampfler JA; Croghan GA; Johnson C; Wu D; Aakre JA; Molina J; Wang L; Pankratz VS; Yang P
    Clin Cancer Res; 2011 Jun; 17(11):3830-40. PubMed ID: 21636554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatty acid synthesis pathway genetic variants and clinical outcome of non-small cell lung cancer patients after surgery.
    Jin X; Zhang KJ; Guo X; Myers R; Ye Z; Zhang ZP; Li XF; Yang HS; Xing JL
    Asian Pac J Cancer Prev; 2014; 15(17):7097-103. PubMed ID: 25227797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pri-let-7a-2 rs1143770C>T is associated with prognosis of surgically resected non-small cell lung cancer.
    Shin KM; Jung DK; Hong MJ; Kang HJ; Lee WK; Yoo SS; Lee SY; Cha SI; Lee J; Kim CH; Seok Y; Cho S; Son JW; Lee EB; Jheon S; Kim YT; Park JY
    Gene; 2016 Feb; 577(2):148-52. PubMed ID: 26625972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms of HIF1A gene are associated with prognosis of early stage non-small-cell lung cancer patients after surgery.
    Liu B; Liu Q; Song Y; Li X; Wang Y; Wan S; Zhang Z; Su H
    Med Oncol; 2014 Apr; 31(4):877. PubMed ID: 24567056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non-small cell lung cancer in the PLCO cancer screening trial.
    Guo Y; Feng Y; Liu H; Luo S; Clarke JW; Moorman PG; Su L; Shen S; Christiani DC; Wei Q
    Mol Carcinog; 2019 Jul; 58(7):1094-1104. PubMed ID: 30989732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression.
    Dziadziuszko R; Merrick DT; Witta SE; Mendoza AD; Szostakiewicz B; Szymanowska A; Rzyman W; Dziadziuszko K; Jassem J; Bunn PA; Varella-Garcia M; Hirsch FR
    J Clin Oncol; 2010 May; 28(13):2174-80. PubMed ID: 20351332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Value of Exon 19 Versus 21 EGFR Mutations Varies According to Disease Stage in Surgically Resected Non-small Cell Lung Cancer Adenocarcinoma.
    Renaud S; Seitlinger J; Guerrera F; Reeb J; Beau-Faller M; Voegeli AC; Siat J; Clément-Duchêne C; Tiotiu A; Santelmo N; Costardi L; Ruffini E; Falcoz PE; Vignaud JM; Massard G
    Ann Surg Oncol; 2018 Apr; 25(4):1069-1078. PubMed ID: 29362963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.
    Izar B; Sequist L; Lee M; Muzikansky A; Heist R; Iafrate J; Dias-Santagata D; Mathisen D; Lanuti M
    Ann Thorac Surg; 2013 Sep; 96(3):962-8. PubMed ID: 23932319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancer.
    Matsumoto Y; Kawaguchi T; Watanabe M; Isa SI; Ando M; Tamiya A; Kubo A; Kitagawa C; Yoshimoto N; Koh Y
    BMC Cancer; 2022 Jul; 22(1):775. PubMed ID: 35840951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel genetic variants in KIF16B and NEDD4L in the endosome-related genes are associated with nonsmall cell lung cancer survival.
    Yang S; Tang D; Zhao YC; Liu H; Luo S; Stinchcombe TE; Glass C; Su L; Shen S; Christiani DC; Wang Q; Wei Q
    Int J Cancer; 2020 Jul; 147(2):392-403. PubMed ID: 31618441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain metastases in resected non-small cell lung cancer: The impact of different tyrosine kinase inhibitors.
    Yun PJ; Wang GC; Chen YY; Wu TH; Huang HK; Lee SC; Chang H; Huang TW
    PLoS One; 2019; 14(5):e0215923. PubMed ID: 31048854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermal Growth Factor Receptor Gene Amplification Predicts Worse Outcome in Patients With Surgically Resected Nonadenocarcinoma Lung Cancer.
    Chang H; Yang Y; Lee JS; Jheon SH; Kim YJ; Chung JH
    Clin Lung Cancer; 2019 Jan; 20(1):7-12.e1. PubMed ID: 30017644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of polymorphisms at HORMAD2 and prognosis in advanced non-small-cell lung cancer patients.
    Zhang K; Tang S; Cao S; Hu L; Pan Y; Ma H; Guo X; Wu S; Shen H; Hu Z
    Cancer Epidemiol; 2014 Aug; 38(4):414-8. PubMed ID: 24797335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Programmed Cell Death Ligand 1 Expression in Resected Non-Small Cell Lung Cancer.
    Yu H; Brustugun OT; Ekman S; Botling J; La Fleur L; Micke P; Solberg S; Berglund A; Rivard C; Hirsch FR
    Clin Lung Cancer; 2021 Jul; 22(4):e555-e562. PubMed ID: 33214079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic Modifiers of Progression-Free Survival in Never-Smoking Lung Adenocarcinoma Patients Treated with First-Line Tyrosine Kinase Inhibitors.
    Chang IS; Jiang SS; Yang JC; Su WC; Chien LH; Hsiao CF; Lee JH; Chen CY; Chen CH; Chang GC; Wang Z; Lo FY; Chen KY; Wang WC; Chen YM; Huang MS; Tsai YH; Su YC; Hsieh WS; Shih WC; Shieh SH; Yang TY; Lan Q; Rothman N; Chen CJ; Chanock SJ; Yang PC; Hsiung CA
    Am J Respir Crit Care Med; 2017 Mar; 195(5):663-673. PubMed ID: 27669169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between sex hormones regulation-related SNP rs12233719 and lung cancer risk among never-smoking Chinese women.
    Qian Y; Xie L; Li L; Feng T; Zhu T; Wang R; Yang Y; Zhou B; Yu H; Qian B
    Cancer Med; 2021 Mar; 10(5):1880-1888. PubMed ID: 33595913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.